The univariate and multivariate analyses revealed that individual expression of EMR1-TC, CD68, and CD163 in tumor centers could not notably predict RFS or OS (Table 4 and Table S2), but combined EMR1-TC+CD68+CD163+ expression in the tumor center area significantly correlated with worse RFS in CRC. This evidence concerns the gene CD163 and neoplasm.